Prognostic Value of Mutations in TP53 and RAS Genes in Breast Cancer
The identification of molecular indicators of higher risk for specific subgroups of cancer patients may allow to develop more aggressive therapeutic strategies aimed at cases with the highest likelihood of response. This would avoid unnecessary toxicity to patients and alleviate the burden of cancer...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
SAGE Publishing
2003-01-01
|
| Серія: | The International Journal of Biological Markers |
| Онлайн доступ: | https://doi.org/10.1177/172460080301800108 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|